BIONTECH SE's ticker is BNTX and the CUSIP is 09075V102. A total of 285 filers reported holding BIONTECH SE in Q4 2023. The put-call ratio across all filers is 1.08 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $152,604 | -49.4% | 1,899 | -41.9% | 0.00% | -50.0% |
Q1 2024 | $301,473 | -26.0% | 3,268 | -15.3% | 0.01% | -25.0% |
Q4 2023 | $407,173 | -49.4% | 3,858 | -47.9% | 0.01% | -52.9% |
Q3 2023 | $804,588 | +1.1% | 7,406 | +0.4% | 0.02% | +6.2% |
Q2 2023 | $795,876 | -40.2% | 7,374 | -31.0% | 0.02% | -40.7% |
Q1 2023 | $1,330,408 | -12.7% | 10,680 | +5.3% | 0.03% | -12.9% |
Q4 2022 | $1,524,282 | -44.9% | 10,147 | -50.5% | 0.03% | -46.6% |
Q3 2022 | $2,764,000 | -12.8% | 20,489 | -3.6% | 0.06% | -3.3% |
Q2 2022 | $3,169,000 | -7.0% | 21,255 | +6.4% | 0.06% | +15.4% |
Q1 2022 | $3,408,000 | -28.1% | 19,981 | +8.6% | 0.05% | -23.5% |
Q4 2021 | $4,743,000 | +3.7% | 18,399 | +9.8% | 0.07% | -2.9% |
Q3 2021 | $4,574,000 | +40.7% | 16,755 | +15.4% | 0.07% | +45.8% |
Q2 2021 | $3,251,000 | +157.0% | 14,520 | +25.3% | 0.05% | +140.0% |
Q1 2021 | $1,265,000 | +189.5% | 11,586 | +116.1% | 0.02% | +185.7% |
Q4 2020 | $437,000 | – | 5,361 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bill & Melinda Gates Foundation | 148,674 | $11,947,443 | 19.99% |
Quinn Opportunity Partners LLC | 683,287 | $54,908,943 | 6.24% |
Krensavage Asset Management, LLC | 132,293 | $10,631 | 4.88% |
Crocodile Capital Partners GmbH | 29,586 | $2,377,531 | 3.78% |
ALTRINSIC GLOBAL ADVISORS LLC | 676,219 | $54,340,958 | 2.42% |
FLOSSBACH VON STORCH AG | 4,379,483 | $351,935,254 | 1.48% |
Systrade AG | 10,000 | $803,600 | 1.38% |
HARDING LOEVNER LP | 2,926,761 | $235,224,417 | 1.30% |
CenterBook Partners LP | 206,234 | $16,572,964 | 1.03% |
SECTORAL ASSET MANAGEMENT INC | 27,265 | $2,191,015 | 0.89% |